Antibody-based spot test for NADH-cytochrome b5 reductase activity for the laboratory diagnosis of congenital methemoglobinemia

Clinica Chimica Acta

Volumn 273, Issue 1, 1998, Pages 13-20

  Lan, Feng Hua ^a,b   Tang, Yu Chai ^a   Huang, Chang Hui ^a   Wu, Yu Shui ^a   Zhu, Zhong Yong ^a  

^a Dongfang Hospital   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Enzyme activity; Monoclonal antibody; NADH cytochrome b5 reductase; Nitrocellulose; Recessive congenital methemoglobinemia

Indexed keywords

CYTOCHROME B5 REDUCTASE; MONOCLONAL ANTIBODY; PYROXYLIN; TETRAZOLIUM;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HEREDITARY METHEMOGLOBINEMIA; HUMAN; NEWBORN; PRIORITY JOURNAL; STAINING;

ADULT; ANTIBODIES, MONOCLONAL; CYTOCHROME REDUCTASES; CYTOCHROME-B(5) REDUCTASE; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOBLOTTING; INFANT, NEWBORN; METHEMOGLOBINEMIA; MOTHERS; SENSITIVITY AND SPECIFICITY;

EID: 0032496426     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00022-9     Document Type: Article

References (14)

1. [1] Jaffe ER, Hultquist DE. Cytochrome b5 reductase deficiency and enzymopenic hereditary methemoglobinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. seventh ed. New York: McGraw-Hill, 1995:3399-414.
2. [2] Tomatsu S, Kobayashi Y, Fukumaki Y, Yubisui T, Orri T, Sakaoki Y. The organization and the complete nucleotide sequence of the human NADH-cytochrome b5 reductase gene. Gene 1989;80:353-61.
3. [3] Scott EM, Griffith IV. The enzyme defect of hereditary methemoglobinemia: diaphorase. Biochim Biophys Acta 1959;34:584-6.
4. [4] Leroux A, Junien C, Kaplan J-C, Bamberger J. Generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation. Nature 1975;258:619-20.
5. [5] Scott EM. The relation of diaphorase of human erythrocytes to inheritance of methemoglobinemia. J Clin Invest 1960;39:1176-9.
6. [6] Hegesh E, Calmonovici N, Avron M. New method for determining ferrohemoglobin reductase (NADH-methemoglobin reductase) in erythrocytes. J Lab Clin Med 1968;72:339-44.
7. [7] Board PG. NADH-ferricyanide reductase, a convenient approach to the evaluation of NADH-methemoglobin reductase in human erythrocytes. Clin Chim Acta 1981;109:233-7.
8. [8] Hultquist DE, Passon PG. Catalysis of methemoglobin reduction by erythrocyte cytochrome b5 and cytochrome b5 reductase. Nature 1971;229:252-4.
9. [9] Kaplan J-C, Beutler E. Electrophoresis of red cell NADH-and NADPH-diaphorase in normal subjects and patients with congenital methemoglobinemia. Biochem Biophys Res Commun 1967;29:605-15.
10. [10] Lan FH, Tang YC, Huang CH, Zhu ZY. Establishments of monoclonal antibodies against human erythrocyte NADH-cytochrome b5 reductase. Hybridoma 1996;15(4):295-8.
11. [11] Moor MR, Conrad ME, Bradley EL, Prchal JT. Studies of nicotinamide adenine dinucleotide methemoglobin reductase activity in a Jewish population. Am J Hematol 1982;12:13-8.
12. [12] Prchal JT, Borgese N, Moore MR, Moreno H, Hegesh E, Hall MK. Congenital methemoglobinemia due to methemoglobin reductase deficiency in two unrelated American Black families. Am J Med 1990;89:516-22.
13. [13] Choury D, Reghis A, Pichard A-L, Kaplan J-C. Endogenous proteolysis of membrane-bound red cell cytochrome b5 reductase in adults and newborns: its possible relevance to the generation of the soluble "methemoglobin reductase". Blood 1983;61:894-8.
14. [14] Choury D, Leroux B, Kaplan J-C. Membrane-bound cytochrome b5 reductase (MetHb reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects. J Clin Invest 1981;67:149-55.